Table 2 Clinical response to everolimus
Outcomes | Patients with tissue samples no. (%) | Patients without tissue samples no. (%)* |
|---|---|---|
CR | 0 (%) | 0 (0%) |
PR | 1 (5.6%) | 0 (0%) |
SD ≥ 6 months | 9 (50.0%) | 3 (60.0%) |
SD < 6 months | 6 (33.3%) | 0 (0%) |
PD | 2 (11.1%) | 2 (40.0%) |
ORR | 1 (5.6%) | 0 (0%) |
CBR (CR + PR + SD ≥ 6 months) | 10 (55.6%) | 3 (60.0%) |
DCR (CR + PR + SD) | 16 (88.9%) | 3 (60.0%) |
PFS (months) | 8.4 (95% CI: 2.163 - 14.637) | 8.6 (95% CI: 1.909 - 15.291) |